Status:
RECRUITING
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Bladder Cancer
Eligibility:
All Genders
Brief Summary
Muscle invasive bladder cancer (MIBC) has a poor prognosis even after radical cystectomy. Postoperative survival stratification based on radiomics and deep learning may be useful for treatment decisio...
Eligibility Criteria
Inclusion
- patients with pathologically confirmed MIBC after radical cystectomy;
- contrast-CT scan less than two weeks before surgery;
- complete CT image data and clinical data.
Exclusion
- patients who received neoadjuvant therapy;
- non-urothelial carcinoma;
- poor quality of CT images;
- incomplete clinical and follow-up data.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06092450
Start Date
August 1 2023
End Date
June 1 2025
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016